Clinical Trials Browser

INDUSTRY × Hematologic Neoplasms × Inotuzumab Ozogamicin × Clear all

NCT04307134 2025-12-31

Besponsa Post Marketing Surveillance Study

108 enrolled 39 charts

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hematologic Neoplasms